After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Recently, Yahoo Finance discussed the stock, revealing that Relay Therapeutics to Participate in Three Upcoming Investor Conferences.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Relay Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $10.08 and fluctuated between $10.43 as its day high and $9.99 as its day low. The current market capitalization of Relay Therapeutics Inc is $1.32B. A total of 0.97 million shares were traded on the day, compared to an average of 1.08M shares.
Insider Activity
Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, RLAY has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 4 BUYs and 29 SELLs from insiders. Insiders purchased 166,370 shares during that period but sold 44,605.
In the most recent transaction, Bergstrom Donald A sold 3,178 shares of RLAY for 9.64 per share on Jan 29. After the transaction, the President, R&D now owns 530,878 company shares. In a previous transaction on Jan 29, Catinazzo Thomas sold 2,005 shares at 9.64 per share. RLAY shares that Chief Financial Officer owns now total 341,846.
Among the insiders who sold shares, Adams Brian disposed of 1,929 shares on Jan 29 at a per-share price of $9.64. This resulted in the Chief Legal Officer holding 327,738 shares of RLAY after the transaction. In another insider transaction, Rahmer Peter sold 1,651 shares at $9.64 per share on Jan 29. Company shares held by the insider now total 514,977.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, RLAY has a high of $19.23 and a low of $5.95.
As of this writing, RLAY has an earnings estimate of -$0.71 per share for the current quarter. EPS was calculated based on a consensus of 8 estimates, with a high estimate of -$0.67 per share and a lower estimate of -$0.81. The company reported an EPS of -$0.54 in the last quarter, which was 34.90% higher than expectations of -$0.83.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. RLAY’s latest balance sheet shows that the firm has $958.07M in Cash & Short Term Investments as of fiscal 2021. There were $22.90M in debt and $24.32M in liabilities at the time. Its Book Value Per Share was $5.90, while its Total Shareholder’s Equity was $897.81M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RLAY is Buy with a score of 4.67.
